Comparison of the effects of retroviral restriction factors involved in resistance to porcine endogenous retrovirus

Journal of Microbiology and Biotechnology

Volumn 24, Issue 4, 2014, Pages 577-583

  Bae, Eun Hye ^a   Jung, Yong Tae ^a  

^a Dankook University   (South Korea)

Author keywords

APOBEC3G; PERVs; Tetherin; Xenotransplantation

Indexed keywords

ANTIRETROVIRUS AGENT; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; TETHERIN; TRIPARTITE MOTIF PROTEIN 5; UNCLASSIFIED DRUG; ANTIVIRUS AGENT; APOBEC3G PROTEIN, HUMAN; BST2 PROTEIN, HUMAN; CARRIER PROTEIN; CYTIDINE DEAMINASE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; LEUKOCYTE ANTIGEN; TRIM5 PROTEIN, HUMAN;

ANTIVIRAL ACTIVITY; ARTICLE; COMPARATIVE EFFECTIVENESS; DRUG DETERMINATION; DRUG POTENCY; DRUG POTENTIATION; DRUG SCREENING; EMBRYO; HUMAN; HUMAN CELL; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PORCINE ENDOGENOUS RETROVIRUS; PROTEIN EXPRESSION; RETROVIRUS; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS RESISTANCE; ANIMAL; CELL LINE; ENDOGENOUS RETROVIRUS; IMMUNOLOGY; PHYSIOLOGY; SWINE;

ANIMALS; ANTIGENS, CD; ANTIVIRAL AGENTS; CARRIER PROTEINS; CELL LINE; CYTIDINE DEAMINASE; ENDOGENOUS RETROVIRUSES; GPI-LINKED PROTEINS; HUMANS; SWINE; VIRUS REPLICATION;

EID: 84899152177     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.1312.12079     Document Type: Article

References (29)

1. Boneva RS, Folks TM, Chapman LE. 2001. Infectious disease issues in xenotransplatation. Clin. Microbiol. Rev. 14: 1-14.
2. Dey A, Mantri CK, Jui PD, Liu B, Pratap S, Dash C. 2011. Downregulation of APOBEC3G by xenotropic murine leukemia-virus related virus (XMRV) in prostate cancer cells. Virol. J. 8: 531.
3. Dieckhoff B, Karlas A, Hofmann A, Kues WA, Petersen B, Pfeifer A, et al. 2007. Inhibition of porcine endogenous retroviruses (PERVs) in primary porcine cells by RNA interference using lentiviral vectors. Arch. Virol. 152: 629-634.
4. Dörrschuck E, Fischer N, Bravo IG, Hanschmann KM, Kuiper H, Spötter A, et al. 2011. Restriction of porcine endogenous retrovirus by porcine APOBEC3 cytidine deaminases. J. Virol. 85: 3842-3857.
5. Dörrschuck E, Münk C, Tönjes RR. 2008. APOBEC3 proteins and porcine endogenous retroviruses. Transplant. Proc. 40: 959-961.
6. Fiebig U, Stephan O, Kurth R, Denner J. 2003. Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation? Virology 307: 406-413.
7. Goila-Gaur R, Strebel K. 2008. HIV-1 Vif, APOBEC, and intrinsic immunity. Retrovirology 5: 51.
8. Harris RS, Liddament MT. 2004. Retroviral restriction by APOBEC proteins. Nature 4: 868-877.
9. Holmes RK, Malim MH, Bishop KN. 2007. APOBECmediated viral restriction: not simply editing? Trends Biochem. Sci. 32: 118-128.
10. Jónsson SR, LaRue RS, Stenglein MD, Fahrenkrug SC, Andrésdóttir V, Harris RS. 2007. The restriction of zoonotic PERV transmission by human APOBEC3G. PLoS One 2: e893.
11. Kaletsky RL, Francica JR, Agrawal-Gamse C, Bates P. 2009. Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proc. Natl. Acad. Sci. USA 106: 2886-2891.
12. Langlois MA, Kemmerich K, Rada C, Neuberger MS. 2009. The AKV murine leukemia virus is restricted and hypermutated by mouse APOBEC3. J. Virol. 83: 11550-11559.
13. Le Tortorec A, Willey S, Neil SJ. 2011. Antiviral inhibition of enveloped virus release by tetherin/BST-2: action and counteraction. Viruses 3: 520-540.
14. Liberatore RA, Bieniasz PD. 2012. Tetherin is a key effector of the antiretroviral activity of type 1 interferon in vitro and in vivo. Proc. Natl. Acad. Sci. USA 108: 18097-18101.
15. Magre S, Takeuchi Y, Bartosch B. 2003. Xenotransplantation and pig endogenous retroviruses. Rev. Med. Virol. 13: 311-329.
16. Mattiuzzo G, Ivol S, Takeuchi Y. 2010. Regulation of porcine endogenous retrovirus release by porcine and human tetherins. J. Virol. 84: 2618-2622.
17. Miyagi E, Brown CR, Opi S, Khan M, Goila-Gaur R, Kao S, et al. 2010. Stably expressed APOBEC3F has negligible antiviral activity. J. Virol. 84: 11067-11075
18. Nakayama EE, Shioda T. 2010. Anti-retroviral activity of TRIM5α. Rev. Med. Virol. 20: 77-92.
19. Patience C, Takeuchi Y, Weiss RA. 1997. Infection of human cells by an endogenous retrovirus of pigs. Nat. Med. 3: 2 8 2-286.
20. Qari SH, Magre S, García-Lerma JG, Hussain AI, Takeuchi Y, Patience C, et al. 2001. Susceptibility of the porcine endogenous retrovirus to reverse transcriptase and protease inhibitors. J. Virol. 75: 1048-1053.
21. Radoshitzky SR, Dong L, Chi X, Clester JC, Retterer C, Spurgers K, et al. 2010. Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin. J. Virol. 84: 10569-10580.
22. Sadler HA, Stenglein MD, Harris RS, Mansky LM. 2010. APOBEC3G contributes to HIV-1 variation through sublethal mutagenesis. J. Virol. 84: 7396-7404.
23. Sanchez-Martinez S, Aloia AL, Harvin D, Mirro J, Gorelick RJ, Jern P, et al. 2012. Studies on the restriction of murine leukemia viruses by mouse APOBEC3. PLoS One 7: e38190.
24. Stieler K, Fischer N. 2010. APOBEC3G efficiently reduces infectivity of the human exogenous gammaretrovirus XMRV. PLoS One 5: e11738.
25. Takeuchi Y, Patience C, Magre S, Weiss RA, Banerjee PT, Le Tissier P, Stoye JP. 1998. Host range and interference studies of three classes of pig endogenous retrovirus. J. Virol. 72: 9986-9991.
26. Tortorec AL, Willey S, Neil SJ. 2011. Antiviral inhibition of enveloped virus release by tetherin/BST-2: action and counteraction. Viruses 3: 520-540.
27. Wood A, Webb BLJ, Bartosch B, Schaller T, Takeuchi Y, Towers GJ. 2009. Porcine endogenous retroviruses PERV A and A/C recombinant are insensitive to a range of divergent mammalian TRIM5α proteins including human TRIM5α. J. Gen. Virol. 90: 702-709.
28. Zennou V, Bieniasz PD. 2006. Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates. Virology 349: 31-40.
29. Zhang J, Liang C. 2010. BST-2 diminishes HIV-1 infectivity. J. Virol. 84: 12336-12343